Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nosocomial bloodstream infections in patients with implantable left ventricular assist devices  Steven M Gordon, MD, Steven K Schmitt, MD, Micah Jacobs,

Published byMartial Lépine Modified over 5 years ago

Similar presentations

Presentation on theme: "Nosocomial bloodstream infections in patients with implantable left ventricular assist devices  Steven M Gordon, MD, Steven K Schmitt, MD, Micah Jacobs,"— Presentation transcript:

1 Nosocomial bloodstream infections in patients with implantable left ventricular assist devices 
Steven M Gordon, MD, Steven K Schmitt, MD, Micah Jacobs, BS, Nicolas M Smedira, MD, Marlene Goormastic, MPH, Michael K Banbury, MD, Mike Yeager, RN, Janet Serkey, RN, Katherine Hoercher, RN, Patrick M McCarthy, MD  The Annals of Thoracic Surgery  Volume 72, Issue 3, Pages (September 2001) DOI: /S (01)

2 Fig 1 Interval from implantation of left ventricular assist device (LVAD) to onset of nosocomial bloodstream infection, by pathogen group. The Annals of Thoracic Surgery  , DOI: ( /S (01) )

3 Fig 2 Kaplan-Meier (K-M) estimates of infection-free time (nosocomial bloodstream infections) by type of left ventricular assist device. The Annals of Thoracic Surgery  , DOI: ( /S (01) )

4 Fig 3 Kaplan-Meier (K-M) estimates of 6-month survival for patients who underwent cardiac transplantation with and without prior nosocomial bloodstream infection on left ventricular assist device support. The Annals of Thoracic Surgery  , DOI: ( /S (01) )

Download ppt "Nosocomial bloodstream infections in patients with implantable left ventricular assist devices  Steven M Gordon, MD, Steven K Schmitt, MD, Micah Jacobs,"

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.
Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W
High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,
Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 
Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.

Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.
Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,
Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy  Francis D Pagani, MD, PhD, Keith D Aaronson, MD, David B Dyke,

Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy  Francis D Pagani, MD, PhD, Keith D Aaronson, MD, David B Dyke,
Laura Harvey, MD, Christopher Holley, MD, Samit S

Laura Harvey, MD, Christopher Holley, MD, Samit S
Robert J. Steffen, MD, Eugene H. Blackstone, MD, Nicholas G

Robert J. Steffen, MD, Eugene H. Blackstone, MD, Nicholas G
Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda.

Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda.
Heart Transplantation for the Failing Fontan

Heart Transplantation for the Failing Fontan
Dhaval Chauhan, MD, Alexis K

Dhaval Chauhan, MD, Alexis K
Continuous Flow Left Ventricular Assist Device Outcomes in Commercial Use Compared With the Prior Clinical Trial  Ranjit John, MD, Yoshifumi Naka, MD,

Continuous Flow Left Ventricular Assist Device Outcomes in Commercial Use Compared With the Prior Clinical Trial  Ranjit John, MD, Yoshifumi Naka, MD,
Extracorporeal Membrane Oxygenation is Superior to Right Ventricular Assist Device for Acute Right Ventricular Failure After Heart Transplantation  Shahrokh.

Extracorporeal Membrane Oxygenation is Superior to Right Ventricular Assist Device for Acute Right Ventricular Failure After Heart Transplantation  Shahrokh.
Factors Influencing HLA Sensitization in Implantable LVAD Recipients

Factors Influencing HLA Sensitization in Implantable LVAD Recipients
Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Nestor R

Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Nestor R
Lung transplantation for primary and secondary pulmonary hypertension

Lung transplantation for primary and secondary pulmonary hypertension
Duration of inotropic support after left ventricular assist device implantation: Risk factors and impact on outcome  Soren Schenk, MD, Patrick M. McCarthy,

Duration of inotropic support after left ventricular assist device implantation: Risk factors and impact on outcome  Soren Schenk, MD, Patrick M. McCarthy,
Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication?  Nishant D. Patel, BA, Jason.

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication?  Nishant D. Patel, BA, Jason.
Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases  Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases  Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Similar presentations

Ads by Google